Strategic consulting for advanced in vitro methods, validation and regulatory readiness
Why InVitroTox Consulting
InVitroTox Consulting was founded by Dr. Helena Kandarova, ERT, to provide focused scientific advisory in areas where advanced in vitro methods require more than routine support.
​
The consultancy combines deep scientific expertise, validation-oriented thinking and cross-sector experience to help organizations make stronger decisions around method readiness, protocol quality, implementation and regulatory relevance.
​
​​
​
What do we offer?
​
Deep scientific expertise
Focused knowledge in advanced in vitro toxicology, reconstructed tissue models and non-animal methods.​
Validation-oriented perspective
Support shaped by scientific robustness, fit-for-purpose use and critical evaluation of strengths and limitations.​ GLP and GIVIMP consultations and implementation.
Cross-sector understanding
A perspective informed by work across research, application, training and expert scientific environments.​
Senior-level guidance
Independent and thoughtful input for decisions that require both technical depth and credibility.
​
Regulatory insights
Understanding OECD guidelines programmes, shaping the content of proposals and guidance documents.
Accelerating scientific progress and practical uptake of NAM technologies
When may you need us?
Whether you are developing a new approach, refining an existing method, preparing for broader review or strengthening internal expertise, InVitroTox Consulting offers senior-level scientific guidance tailored to your needs.
​​
We work with organisations that need more than general consulting.
​
Our focus is on projects and decisions where scientific quality, method robustness, practical implementation and external credibility must work together.
Who do we work with?
InVitroTox Consulting supports a range of organizations operating at the interface of science, innovation and applied decision-making.
Biotech and in vitro technology developers
Support for teams developing new methods, models or platforms that require scientific review and strategic refinement.
Pharma, cosmetics and chemicals companies
Expert input for organizations working with non-animal testing approaches, study planning and method-related decision-making.
Medical device stakeholders
Scientific advisory for projects involving irritation-related questions, testing strategies and applied interpretation.
Research consortia, laboratories and institutions
Senior-level support for collaborative projects, method-focused activities, training and impact-oriented scientific work.
